Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE
Aniek E M Schouten, Geert W J Frederix, Martijn M Stuiver, Felix Fischer, Anouk E Hiensch, Krister Cromm, Bernard Canaud, Giovanni F M Strippoli · 2026
Read Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE by Aniek E M Schouten, Geert W J Frederix, Martijn M Stuiver, Felix Fischer, Anouk E Hiensch, Krister Cromm, Bernard Canaud, Giovanni F M Strippoli (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0350019.txt.
Description
Aniek E M Schouten and co-authors tested a quiet choice that can sway whether a treatment looks worth its cost. Health economists convert quality-of-life survey answers into scores using value sets, and each European country has its own. Their 2026 study re-ran cost analyses from two multinational trials, one on exercise for breast cancer patients and one on a kidney treatment, swapping value sets across countries.
The same answers produced noticeably different scores and health gains depending on which country's values were applied, and the gaps grew when patients reported poor quality of life. Odds that a treatment counted as cost-effective shifted by up to about eleven percentage points. The authors advise testing several value sets in multinational studies instead of trusting just one.
Catalog record
| CREATOR | Aniek E M Schouten, Geert W J Frederix, Martijn M Stuiver, Felix Fischer, Anouk E Hiensch, Krister Cromm, Bernard Canaud, Giovanni F M Strippoli |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37789 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |